Switching indication of PEGylated lipid nanocapsules-loaded with rolapitant and deferasirox against breast cancer: Enhanced in-vitro and in-vivo cytotoxicity
Mohamed Fawzi Kabil, Mohamed Y. Mahmoud, Alaa F. Bakr, Dalia Zaafar, Ibrahim M. El‐Sherbiny
Topics & Concepts
In vivoCytotoxicityPharmacologyChemistryPaclitaxelCancer researchIn vitroMedicineCancerInternal medicineBiochemistryBiologyBiotechnologyNanoparticle-Based Drug DeliveryComputational Drug Discovery MethodsDrug Transport and Resistance Mechanisms